Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia

Patients who meet task force criteria for ARVD are at high risk for sudden cardiac death and should undergo ICD placement for primary and secondary prevention, regardless of electrophysiologic testing results. Further research is needed to confirm that a low-risk subset of patients who may not require ICD placement can be identified.